KINNATE BIOPHARMA INC - COM (KNTE) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2024

Type / Class
Equity / COM
Symbol
KNTE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KINNATE BIOPHARMA INC - COM (KNTE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$4,176 0
2024 Q2 0 $0 -$92,061,843 0
2024 Q1 34,598,592 $92,061,843 -$8,961,422 $2.66 54
2023 Q4 38,399,235 $91,004,509 +$3,736,313 $2.37 61
2023 Q3 38,578,902 $54,009,394 -$5,570,966 $1.40 55
2023 Q2 40,054,940 $121,364,042 -$32,306,355 $3.03 70
2023 Q1 43,259,915 $270,371,124 +$15,334,623 $6.25 70
2022 Q4 40,833,657 $249,084,093 -$18,259,465 $6.10 79
2022 Q3 43,587,619 $520,873,933 +$5,424,992 $11.95 81
2022 Q2 43,103,604 $543,538,404 +$23,550,662 $12.61 70
2022 Q1 41,300,767 $464,935,698 -$24,793,990 $11.26 74
2021 Q4 42,355,264 $750,531,983 -$6,152,395 $17.72 69
2021 Q3 36,572,441 $841,897,400 +$23,499,837 $23.02 70
2021 Q2 38,294,063 $890,928,000 +$7,677,776 $23.28 61
2021 Q1 35,090,237 $1,091,390,312 +$51,750,405 $31.16 61
2020 Q4 33,262,560 $1,318,124,000 +$1,283,316,000 $39.78 54